Literature DB >> 30521696

Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.

Jan Klimas1, Christopher Fairgrieve, Helen Tobin, Catherine-Anne Field, Clodagh Sm O'Gorman, Liam G Glynn, Eamon Keenan, Jean Saunders, Gerard Bury, Colum Dunne, Walter Cullen.   

Abstract

BACKGROUND: Problem alcohol use is common among people who use illicit drugs (PWID) and is associated with adverse health outcomes. It is also an important factor contributing to a poor prognosis among drug users with hepatitis C virus (HCV) as it impacts on progression to hepatic cirrhosis or opioid overdose in PWID.
OBJECTIVES: To assess the effectiveness of psychosocial interventions to reduce alcohol consumption in PWID (users of opioids and stimulants). SEARCH
METHODS: We searched the Cochrane Drugs and Alcohol Group trials register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, CINAHL, and PsycINFO, from inception up to August 2017, and the reference lists of eligible articles. We also searched: 1) conference proceedings (online archives only) of the Society for the Study of Addiction, International Harm Reduction Association, International Conference on Alcohol Harm Reduction and American Association for the Treatment of Opioid Dependence; and 2) online registers of clinical trials: Current Controlled Trials, ClinicalTrials.gov, Center Watch and the World Health Organization International Clinical Trials Registry Platform. SELECTION CRITERIA: We included randomised controlled trials comparing psychosocial interventions with other psychosocial treatment, or treatment as usual, in adult PWIDs (aged at least 18 years) with concurrent problem alcohol use. DATA COLLECTION AND ANALYSIS: We used the standard methodological procedures expected by Cochrane. MAIN
RESULTS: We included seven trials (825 participants). We judged the majority of the trials to have a high or unclear risk of bias.The psychosocial interventions considered in the studies were: cognitive-behavioural coping skills training (one study), twelve-step programme (one study), brief intervention (three studies), motivational interviewing (two studies), and brief motivational interviewing (one study). Two studies were considered in two comparisons. There were no data for the secondary outcome, alcohol-related harm. The results were as follows.Comparison 1: cognitive-behavioural coping skills training versus twelve-step programme (one study, 41 participants)There was no significant difference between groups for either of the primary outcomes (alcohol abstinence assessed with Substance Abuse Calendar and breathalyser at one year: risk ratio (RR) 2.38 (95% confidence interval [CI] 0.10 to 55.06); and retention in treatment, measured at end of treatment: RR 0.89 (95% CI 0.62 to 1.29), or for any of the secondary outcomes reported. The quality of evidence for the primary outcomes was very low.Comparison 2: brief intervention versus treatment as usual (three studies, 197 participants)There was no significant difference between groups for either of the primary outcomes (alcohol use, measured as scores on the Alcohol Use Disorders Identification Test (AUDIT) or Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) at three months: standardised mean difference (SMD) 0.07 (95% CI -0.24 to 0.37); and retention in treatment, measured at three months: RR 0.94 (95% CI 0.78 to 1.13), or for any of the secondary outcomes reported. The quality of evidence for the primary outcomes was low.Comparison 3: motivational interviewing versus treatment as usual or educational intervention only (three studies, 462 participants)There was no significant difference between groups for either of the primary outcomes (alcohol use, measured as scores on the AUDIT or ASSIST at three months: SMD 0.04 (95% CI -0.29 to 0.37); and retention in treatment, measured at three months: RR 0.93 (95% CI 0.60 to 1.43), or for any of the secondary outcomes reported. The quality of evidence for the primary outcomes was low.Comparison 4: brief motivational intervention (BMI) versus assessment only (one study, 187 participants)More people reduced alcohol use (by seven or more days in the past month, measured at six months) in the BMI group than in the control group (RR 1.67; 95% CI 1.08 to 2.60). There was no difference between groups for the other primary outcome, retention in treatment, measured at end of treatment: RR 0.98 (95% CI 0.94 to 1.02), or for any of the secondary outcomes reported. The quality of evidence for the primary outcomes was moderate.Comparison 5: motivational interviewing (intensive) versus motivational interviewing (one study, 163 participants)There was no significant difference between groups for either of the primary outcomes (alcohol use, measured using the Addiction Severity Index-alcohol score (ASI) at two months: MD 0.03 (95% CI 0.02 to 0.08); and retention in treatment, measured at end of treatment: RR 17.63 (95% CI 1.03 to 300.48), or for any of the secondary outcomes reported. The quality of evidence for the primary outcomes was low. AUTHORS'
CONCLUSIONS: We found low to very low-quality evidence to suggest that there is no difference in effectiveness between different types of psychosocial interventions to reduce alcohol consumption among people who use illicit drugs, and that brief interventions are not superior to assessment-only or to treatment as usual. No firm conclusions can be made because of the paucity of the data and the low quality of the retrieved studies.

Entities:  

Mesh:

Year:  2018        PMID: 30521696      PMCID: PMC6517179          DOI: 10.1002/14651858.CD009269.pub4

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  98 in total

1.  Engaging general practitioners in the management of hazardous and harmful alcohol consumption: results of a meta-analysis.

Authors:  Peter Anderson; Miranda Laurant; Eileen Kaner; Michel Wensing; Richard Grol
Journal:  J Stud Alcohol       Date:  2004-03

2.  Variation among state-level approaches to addressing alcohol abuse in opioid treatment programs.

Authors:  Gavin H Harris; Shiela M Strauss; Carina Katigbak; Bhupinder S Brar; Lawrence S Brown; Steven S Kipnis; Steven A Kritz; Mark W Parrino
Journal:  J Subst Abuse Treat       Date:  2010-04-24

Review 3.  A new work placement model for unemployed methadone maintenance patients.

Authors:  Laura Blankertz; Stephen Magura; Graham L Staines; Elizabeth M Madison; Michael Spinelli; Emily Horowitz; Priti Bali; Honoria Guarino; Audrey Grandy; Rebecca Young
Journal:  Subst Use Misuse       Date:  2004       Impact factor: 2.164

4.  Psychosocial Interventions for Problem Alcohol Use in Primary Care Settings (PINTA): Baseline Feasibility Data.

Authors:  Jan Klimas; Anne Marie Henihan; Geoff McCombe; Davina Swan; Rolande Anderson; Gerard Bury; Colum Dunne; Eamon Keenan; Jean Saunders; Gillian Williams Shorter; Bobby P Smyth; Walter Cullen
Journal:  J Dual Diagn       Date:  2015

5.  Effect of motivational interviewing on reduction of alcohol use.

Authors:  Adeline Nyamathi; Steven Shoptaw; Allan Cohen; Barbara Greengold; Kamala Nyamathi; Mary Marfisee; Viviane de Castro; Farinaz Khalilifard; Daniel George; Barbara Leake
Journal:  Drug Alcohol Depend       Date:  2010-02-01       Impact factor: 4.492

6.  Unintentional drug overdose death trends in New Mexico, USA, 1990-2005: combinations of heroin, cocaine, prescription opioids and alcohol.

Authors:  Nina G Shah; Sarah L Lathrop; R Ross Reichard; Michael G Landen
Journal:  Addiction       Date:  2007-11-20       Impact factor: 6.526

7.  Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram.

Authors:  K M Carroll; C Nich; S A Ball; E McCance; B J Rounsavile
Journal:  Addiction       Date:  1998-05       Impact factor: 6.526

8.  The effect of alcoholism in methadone-maintained persons on productive activity: a randomized control trial.

Authors:  M Cohen; D Korts; R Hanbury; V Sturiano; G Jackson; B Stimmel
Journal:  Alcohol Clin Exp Res       Date:  1982       Impact factor: 3.455

Review 9.  Alcohol use in opioid agonist treatment.

Authors:  Seonaid Nolan; Jan Klimas; Evan Wood
Journal:  Addict Sci Clin Pract       Date:  2016-12-08

10.  Examining multi-session brief intervention for substance use in primary care: research methods of a randomized controlled trial.

Authors:  Jaclyn E Chambers; Adam C Brooks; Rachel Medvin; David S Metzger; Jennifer Lauby; Carolyn M Carpenedo; Kevin E Favor; Kimberly C Kirby
Journal:  Addict Sci Clin Pract       Date:  2016-04-18
View more
  8 in total

Review 1.  Prevention, screening, and treatment for heavy drinking and alcohol use disorder.

Authors:  Justin Knox; Deborah S Hasin; Farren R R Larson; Henry R Kranzler
Journal:  Lancet Psychiatry       Date:  2019-10-17       Impact factor: 27.083

Review 2.  Music therapy for people with substance use disorders.

Authors:  Claire Ghetti; Xi-Jing Chen; Annette K Brenner; Laurien G Hakvoort; Lars Lien; Jorg Fachner; Christian Gold
Journal:  Cochrane Database Syst Rev       Date:  2022-05-09

Review 3.  Motivational interviewing for smoking cessation.

Authors:  Nicola Lindson; Tom P Thompson; Anne Ferrey; Jeffrey D Lambert; Paul Aveyard
Journal:  Cochrane Database Syst Rev       Date:  2019-07-31

4.  Practice Habits, Knowledge, and Attitudes of Hepatologists to Alcohol Use Disorder Medication: Sobering Gaps and Opportunities.

Authors:  Thomas G Cotter; Fares Ayoub; Andrea C King; Kapuluru Gautham Reddy; Michael Charlton
Journal:  Transplant Direct       Date:  2020-09-17

5.  Preliminary Effectiveness of a Remotely Monitored Blood Alcohol Concentration Device as Treatment Modality: Protocol for a Randomized Controlled Trial.

Authors:  Frank D Buono; Colette Gleed; Martin Boldin; Allison Aviles; Natalie Wheeler
Journal:  JMIR Res Protoc       Date:  2022-01-14

6.  Treatment of Opioid Use Disorder in Canadian Psychosocial Addiction Programs: A National Survey of Policy, Attitudes, and Practice.

Authors:  David C Hodgins; Mathew Budd; Gail Czukar; Simon Dubreucq; Lois A Jackson; Brian Rush; Lena C Quilty; Denise Adams; T Cameron Wild
Journal:  Can J Psychiatry       Date:  2022-03-08       Impact factor: 5.321

7.  Oxytocin-enhanced group therapy for methamphetamine use disorder: Randomized controlled trial.

Authors:  Christopher S Stauffer; Jenna M Moschetto; Scott McKernan; Nathan Meinzer; Chavy Chiang; Rachel Rapier; Elaine Hsiang; Jerika Norona; Brian Borsari; Joshua D Woolley
Journal:  J Subst Abuse Treat       Date:  2020-06-15

8.  Differential Influence of Pueraria lobata Root Extract and Its Main Isoflavones on Ghrelin Levels in Alcohol-Treated Rats.

Authors:  Michał Szulc; Radosław Kujawski; Justyna Baraniak; Małgorzata Kania-Dobrowolska; Ewa Kamińska; Agnieszka Gryszczyńska; Kamila Czora-Poczwardowska; Hanna Winiarska; Przemysław Ł Mikołajczak
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.